Pediatric Fungal Diagnostics


This reference library was created for the community of providers who care for children with these illnesses. It was developed to assist clinicians in understanding, diagnosing and treating pediatric invasive fungal infections. The library links to important references within each category but is not meant to be comprehensive. 


Return to Library Home











International Pediatric Fungal Network, Box 3499, Duke University Medical Center, Durham, NC 27710. USA.   Tel: 919-668-4847 Email:

Galactomannan antigen testing for diagnosis of invasive aspergillosis in pediatric hematology patients. 

Fisher BT et al. J Pediatric Infect Dis Soc. 2012 Jun;1(2):103-111. Epub 2012 May 3.


High levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease. 

Mularoni A et al. Clin Vaccine Immunol. 2010 May;17(5):882-3. 


Canadian clinical practice guidelines for invasive candidiasis in adults. 

Bow EJ et al. Can J Infect Dis Med Microbiol. 2010 Winter;21(4):e122-50.


Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods. 

Oz Y et al. Expert Rev Anti Infect Ther. 2011 Mar;9(3):289-98. 


Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients. 

Landlinger C et al. Leukemia. 2010 Dec;24(12):2032-8. 


Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. 

Steinbach et al. Pediatr Infect Dis J. 2007 Jul;26(7):558-64.


Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis. 

Hayden et al. Pediatr Infect Dis J. 2008 Sep;27(9):815-9. 


(1-3)-B-D-glucan levels in candidiasis infections in the critically ill neonate. 

Goudjil S et al. J Matern Fetal Neonatal Med. 2013 Jan;26(1):44-8.


Application of diagnostic markers to invasive aspergillosis in children. 

Roilides E et al. Ann N Y Acad Sci. 2012 Dec;1272:1-8.


Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients. 

Choi SH et al. Pediatr Blood Cancer. 2013 Feb;60(2):316-22.


The role of biomarkers for diagnosis of and therapeutic decisions related to invasive aspergillosis in children. 

Fischer BT et al. Curr Fungal Infect Rep. 2013 Mar 1;7(1):7-14.


Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies. 

Jha AK et al. Mycoses. 2013 Jul;56(4):442-8.